Houston, TXNCT05791786Now EnrollingIRB Ready

Amniotic Fluid Embolism Clinical Trial in Houston, TX

Access cutting-edge amniotic fluid embolism treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.

Sponsored by The University of Texas Health Science Center, Houston

Quick Self-Assessment

See if you qualify for this Houston location

Preparing your pre-screening questions…

Expert Care in Houston

Access amniotic fluid embolism specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related amniotic fluid embolism treatment provided free

Apply for This Houston Location

Check if you qualify for this amniotic fluid embolism clinical trial in Houston, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Houston

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Houston site if eligible
  4. 4Begin participation

About This Amniotic Fluid Embolism Study in Houston

To establish a clinical registry of suspected cases of AFE. The existing registry will be migrated to a new platform,

Sponsor: The University of Texas Health Science Center, Houston

Who Can Participate

Inclusion Criteria

for participants of the AFE registry and biorepository include affected individuals diagnosed with AFE (see below).
All subjects or their next of kin must be able to provide a signed and dated informed consent form.
In the case of lethal AFE, the surviving family member or next of kin must be able to provide a signed and dated informed consent form with an accompanying death certificate and proof of legal kinship.
Participants are expected to be willing to permit collection of data about their affected pregnancy, previous and future pregnancies, and their current and future health conditions.
Providing biological samples is not required for enrollment.
Any maternal death in the Hermann Hospital System suspected of having an AFE within 24 hours of childbirth between 1/2012 and 1/2023 will also be included for data analysis and biospecimen studies
Medical records will be abstracted into a comprehensive case report form and then reviewed by a team of three experts with consensus to determine case classification of three categories, according to criteria previously reported and based on data generated from the previously existing registry: (1) Classic AFE is defined by the following indicators:
Acute hypotension or cardiac arrest,
Acute hypoxia, defined as dyspnea, cyanosis, or respiratory arrest,
Coagulopathy, defined as laboratory evidence of intravascular consumption or fibrinolysis or severe clinical hemorrhage in the absence of other explanations,
Onset of the above during labor, cesarean section, or dilation and evacuation or within 30 minutes post-partum, and
Absence of any other significant confounding condition or potential explanation for the signs and symptoms observed. (2) Not AFE:
Anything that clinically appears to be a likely result of another pathophysiology, e.g., delayed treatment of postpartum hemorrhage from uterine atony. (3) Atypical AFE:
Subjective determination by the chart reviewer that lies between "classic" and "not," e.g., the patient presents some of the registry criteria and no other explanation. (4) Indeterminate: There is not sufficient information to classify in 1-3 above. The classification of AFE is for research purposes only.

Exclusion Criteria

The inability of an individual to provide a signed and dated informed consent form or those who do not wish to participate.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Houston?

Yes, this clinical trial (NCT05791786) has an active research site in Houston, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Amniotic Fluid Embolism Treatment Options in Houston, TX

If you're searching for amniotic fluid embolism treatment options in Houston, TX, this clinical trial (NCT05791786) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced amniotic fluid embolism specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all amniotic fluid embolism clinical trials near you to find additional studies recruiting in your area.

More Follicular Lymphoma Trials in Houston, TX

See all follicular lymphoma clinical trials recruiting in Houston — not just this study.

Browse Follicular Lymphoma Trials in Houston →

Browse More Trials by Condition

Follicular Lymphoma TrialsInfluenza TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Houston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Houston, TX